• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jul 13, 2018
Clinical News

Acceleron, Celgene score second win with latest luspatercept readout

Read More
BioCentury | Jul 10, 2018
Clinical News

Latest luspatercept readout a second win for Acceleron, Celgene

Read More
BioCentury | Feb 28, 2018
Financial News

Celgene's slide continues after refusal to file letter

Read More
BioCentury | Nov 3, 2017
Clinical News

Celgene reports detailed Phase III data for MS candidate ozanimod

Read More
BioCentury | Oct 30, 2017
Clinical News

Celgene reports detailed Phase III data for MS candidate ozanimod

Read More
BioCentury | Oct 28, 2017
Product Development

Chinks in the armor

What’s next for Celgene in light of mongersen failure, Otezla underperformance
Read More
BioCentury | Oct 26, 2017
Company News

Celgene falls after lowering 2020 guidance

Read More
BioCentury | Oct 20, 2017
Financial News

Celgene late-stage failure drags down biotech indexes

Read More
BioCentury | Oct 20, 2017
Clinical News

Celgene discontinues Phase III of mongersen for CD

Read More
BioCentury | Oct 19, 2017
Clinical News

Celgene halts Phase III trial of mongersen for Crohn's

Read More
Items per page:
1 - 10 of 24